Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching
European Journal of Cancer · 2026-06 · 242 · 116818
DOI: 10.1016/j.ejca.2026.116818 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von Giuseppe Di Grazia und 31 weiteren Autor:innen. Beteiligte Einrichtung: Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Departme…. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Human Pathology "G. Barresi", University of Messina, Messina, It…
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori - IRCCS - "Fondazione G. Pascale", Naples, Italy.
- Department of Medical Oncology, University Hospital of Salamanca, Salamanca, Spain; Institute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain.
- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
- Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
- Department of Medical Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Di Grazia, G., Di Lauro, V., Morchón-Araujo, D., Nucera, S., Figuero-Pérez, L., Calleja-Holgado, F. J., Pelegrina Sánchez, D., Wallbaum, B., Rivera Vargas, P., Palleschi, M., Musolino, A., Zatta Cobos, G., López Paradís, A., Barroso, G., Cano Cano, O., Dalmau Portulas, E., Caltavituro, A., Buono, G., Jerez Gillaranz, Y., …, & Schettini, F. (2026). Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching. European Journal of Cancer, 242, 116818. https://doi.org/10.1016/j.ejca.2026.116818
Vancouver
Di Grazia G, Di Lauro V, Morchón-Araujo D, Nucera S, Figuero-Pérez L, Calleja-Holgado FJ, et al. Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching. European Journal of Cancer. 2026;242:116818. doi:10.1016/j.ejca.2026.116818
BibTeX
@article{DiGrazia2026,
author = {Di Grazia, Giuseppe and Di Lauro, Vincenzo and Morchón-Araujo, Daniel and Nucera, Sabrina and Figuero-Pérez, Luis and Calleja-Holgado, Francisco Javier and Pelegrina Sánchez, David and Wallbaum, Benjamin and Rivera Vargas, Pablo and Palleschi, Michela and Musolino, Antonino and Zatta Cobos, Gastón and López Paradís, Assumpció and Barroso, Gimena and Cano Cano, Ona and Dalmau Portulas, Elsa and Caltavituro, Aldo and Buono, Giuseppe and Jerez Gillaranz, Yolanda and Echavarría, Isabel and López-Tarruella, Sara and Bergamino Sirvén, Milana and Martínez-Sáez, Olga and Adamo, Barbara and Muñoz Mateu, Montserrat and Arpino, Grazia and Sánchez Bayona, Rodrigo and De Laurentiis, Michelino and Rodríguez, César A and Pascual, Tomás and Vidal Losada, María and Schettini, Francesco},
title = {Association between chemotherapy use and prognosis in young patients with stage I-II ER+ /HER2-negative breast cancer according to Prosigna®: An international real-world analysis with propensity-score matching},
journal = {European Journal of Cancer},
year = {2026},
volume = {242},
pages = {116818},
doi = {10.1016/j.ejca.2026.116818}
}
EUVIMED